Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
90.40
+0.26 (0.29%)
Jul 23, 2026, 12:10 PM EDT - Market open
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.41 billion as of July 23, 2026. Its market cap has increased by 735.10% in one year.
Market Cap
4.41B
Enterprise Value
4.30B
1-Year Change
735.10%
Ranking
Category
Stock Price
$90.40
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.41B, an increase of 3,192.36%. That is a compound annual growth rate of 48.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 4.41B | -4.48% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.74B |
| Veradermics | 4.71B |
| Legend Biotech | 4.57B |
| Caris Life Sciences | 4.46B |
| Viking Therapeutics | 4.32B |
| ACADIA Pharmaceuticals | 4.31B |
| Relay Therapeutics | 4.29B |
| Edgewise Therapeutics | 4.24B |